Skip to main content

Table 2 Comparison of patients with and without pneumothorax

From: Risk of iatrogenic pneumothorax based on location of transbronchial biopsy: a retrospective cohort study

Variable

Pneumothorax (n = 38)

No pneumothorax (n = 184)

aOR (95% CI)

Sex

 Male

21 (18.4%)

93 (81.5%)

[ref]

 Female

17 (15.7%)

91 (84.3%)

0.80 (0.40–1.62)

BMI

 <  = 30

30 (18.1%)

136 (81.9%)

[ref]

 > 30

8 (14.3%)

48 (85.7%)

0.76 (0.32–1.86)

Number of biopsies obtained

 1–4

23 (20.5%)

89 (79.5%)

[ref]

 >  = 5

15 (13.9%)

93 (86.1%)

0.63 (0.31–1.27)

Patient location

 Outpatient

18 (12.9%)

122 (87.1%)

[ref]

 Inpatient

19 (24.4%)

59 (75.6%)

2.18 (1.07–4.46)

Location of biopsy

 Right lower lobe

11 (12.9%)

74 (87.1%)

[ref]

 Right middle lobe

4 (15.4%)

22 (84.6%)

1.22 (0.35–4.22)

 Right upper lobe

5 (12.8%)

34 (87.2%)

0.99 (0.31–3.07)

 Left upper lobe

6 (16.7%)

30 (83.3%)

3.08 (1.19–8.01)

 Left lower lobe

11 (31.4%)

24 (68.6%)

1.35 (0.45–3.97)

Indication for biopsy

 Suspected interstitial lung disease

4 (17.4%)

19 (82.6%)

[ref]

 Suspected atypical infection

19 (19.8%)

77 (80.2%)

1.17 (0.36–3.85)

 Suspected malignancy

10 (14.7%)

58 (85.4%)

0.82 (0.23–2.92)

 Other

5 (14.3%)

30 (85.7%)

0.79 (0.19–3.33)

  1. OR odds ratio, CI confidence interval
  2. aUnivariable logistic regression for primary outcome of post-procedure pneumothorax following transbronchial biopsy